摘要 |
<p>The invention relates to a medicament containing a compound of general formu la (I), where R1 = independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C11-C21 alkyl, alkylene or alkinyl group, preferably a C11-C15 alkyl, alkylene or alkinyl group, particularly a C11-C13 alkyl, alkylene or alkinyl group, most preferably a C 13 alkyl group, R2 = independently, a straight or branched C1-C8 alkyl, alkylen e or alkinyl group, preferably a C1-C6 alkyl, alkylene or alkinyl group, in particular a C2-C4 alkyl, alkylene or alkinyl group, most preferably a C3 alkyl group, a -[CH2-(CH2)m-O]nH group with n = 1 to 10, preferably n = 1 to 5, m = 1 to 5, preferably m = 1 to 3, a -CH2-[CH-(OH)]p [CH2-(R3)]- group, where R3 = independently H or OH, p = 1 to 7, preferably p = 1 to 4, a pento se group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combinati on preparation for the treatment of viral skin diseases and/or tumour diseases, in particular caused by human papilloma virus (HPV) and/or herpes viruses an d a topically acting medicament formulation and the use thereof.</p> |
申请人 |
MEDIGENE AKTIENGESELLSCHAFT |
发明人 |
CHANG, YUNIK;BOHM, ERWIN;GANDER-MEISTERERNST, IRENE;GREGER, REGINA;HOLLDACK, JOHANNA;LATHROP, ROBERT;MOEBIUS, ULRICH |